Literature DB >> 17372744

[Autoantibody profile in rheumatoid arthritis].

E Feist1, K Egerer, G-R Burmester.   

Abstract

Antibodies against citrullinated protein/peptides antigens (ACPA) are well recognized serological markers for rheumatoid arthritis. In addition to rheumatoid factor, they provide high diagnostic specificity and are also useful diagnostic tools in the search for early disease manifestation. As shown by several studies, both autoantibodies correlate with disease severity and the radiologic progression of rheumatoid arthritis. However, it is important to note that only the detection of rheumatoid factors is internationally standardized. Whether autoantibody profiling is also of significance for the stratification and monitoring of rheumatoid arthritis is the focus of ongoing investigations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372744     DOI: 10.1007/s00393-007-0159-3

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  37 in total

1.  Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides.

Authors:  Sabine Chapuy-Regaud; Mireille Sebbag; Dominique Baeten; Cyril Clavel; Céline Foulquier; Filip De Keyser; Guy Serre
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

2.  Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins.

Authors:  Mireille Sebbag; Nathalie Moinard; Isabelle Auger; Cyril Clavel; Jacques Arnaud; Leonor Nogueira; Jean Roudier; Guy Serre
Journal:  Eur J Immunol       Date:  2006-08       Impact factor: 5.532

Review 3.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

Review 4.  Autoantibodies to the A/B proteins of the heterogeneous nuclear ribonucleoprotein complex: novel tools for the diagnosis of rheumatic diseases.

Authors:  G Steiner; K Skriner; J S Smolen
Journal:  Int Arch Allergy Immunol       Date:  1996-12       Impact factor: 2.749

5.  Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.

Authors:  M M J Nielen; A R van der Horst; D van Schaardenburg; I E van der Horst-Bruinsma; R J van de Stadt; L Aarden; B A C Dijkmans; D Hamann
Journal:  Ann Rheum Dis       Date:  2005-01-07       Impact factor: 19.103

6.  Antibodies to cyclic citrullinated peptides in psoriatic arthritis.

Authors:  Laura Bogliolo; Claudia Alpini; Roberto Caporali; Carlo Alberto Scirè; Remigio Moratti; Carlomaurizio Montecucco
Journal:  J Rheumatol       Date:  2005-03       Impact factor: 4.666

7.  Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.

Authors:  Floris A van Gaalen; Jill van Aken; Tom W J Huizinga; Geziena M Th Schreuder; Ferdinand C Breedveld; Eric Zanelli; Walther J van Venrooij; Cornelis L Verweij; René E M Toes; René R P de Vries
Journal:  Arthritis Rheum       Date:  2004-07

8.  Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.

Authors:  Holger Bang; Karl Egerer; Anke Gauliard; Kirsten Lüthke; Paul E Rudolph; Gert Fredenhagen; Wigbert Berg; Eugen Feist; Gerd-R Burmester
Journal:  Arthritis Rheum       Date:  2007-08

9.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

Authors:  F A van Gaalen; S P Linn-Rasker; W J van Venrooij; B A de Jong; F C Breedveld; C L Verweij; R E M Toes; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2004-03

10.  Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.

Authors:  Luis M Amezcua-Guerra; Rashidi Springall; Ricardo Marquez-Velasco; Lorena Gómez-García; Angélica Vargas; Rafael Bojalil
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  3 in total

1.  [Rheumatoid factor or antinuclear antibodies as incidental finding].

Authors:  R Biesen; G-R Burmester; F Hiepe
Journal:  Internist (Berl)       Date:  2014-10       Impact factor: 0.743

Review 2.  [Antibodies against citrullinated peptides in clinical practice and research].

Authors:  R Engelmann; B Müller-Hilke
Journal:  Z Rheumatol       Date:  2009-08       Impact factor: 1.372

Review 3.  The serological diagnosis of rheumatoid arthritis: antibodies to citrullinated antigens.

Authors:  Karl Egerer; Eugen Feist; Gerd-Rüdiger Burmester
Journal:  Dtsch Arztebl Int       Date:  2009-03-06       Impact factor: 5.594

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.